BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2732133)

  • 1. In-vitro activity of the new penems FCE 22101 and FCE 24362 alone or in combination with aminoglycosides against streptococci isolated from patients with endocarditis.
    Dornbusch K; Henning C; Lindén E
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():109-17. PubMed ID: 2732133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activity of netilmicin compared with gentamicin and streptomycin, alone and in combination with penicillin, against penicillin tolerant viridans streptococci and enterococci.
    Shanson DC; Tadayon M; Bakhtiar M
    J Antimicrob Chemother; 1986 Oct; 18(4):479-90. PubMed ID: 3095305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy and cumulated killing effect of the penems FCE 22101 and FCE 25199 in combination with gentamicin against bacteria isolated from septicaemia.
    Bergholm AM; Dornbusch K
    APMIS; 1991 Oct; 99(10):916-24. PubMed ID: 1930964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antistreptococcal activity of Sch 34343, a new penem antibiotic.
    Yu PK; Washington JA
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():67-71. PubMed ID: 3928578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():95-101. PubMed ID: 2786520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis.
    Shanson DC; Tadayon M
    J Hosp Infect; 1986 Mar; 7 Suppl A():65-72. PubMed ID: 2871099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of two new carbapenems FCE 22101 and CGP 31608 in comparison with imipenem.
    Van der Auwera P; Ernst F; Grenier P; Glupczynski Y; Husson M; Klastersky J
    J Antimicrob Chemother; 1987 Aug; 20(2):179-89. PubMed ID: 3478328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis.
    Thornsberry C; Baker CN; Facklam RR
    Antimicrob Agents Chemother; 1974 Mar; 5(3):228-33. PubMed ID: 4840433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The killing effects of cefathiamidine or ampicillin alone and in combination with gentamicin against enterococci.
    Chen HY; Williams JD
    J Antimicrob Chemother; 1983 Jul; 12(1):19-26. PubMed ID: 6413484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the combination effects of ampicillin or vancomycin combined with streptomycin, gentamicin, tobramycin or netilmicin against enterococci.
    Fuursted K
    APMIS; 1989 Jan; 97(1):23-6. PubMed ID: 2914103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro interactions of FCE 22101 with aminoglycosides against gram-negative rods.
    Said AA; Livermore DM
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():103-8. PubMed ID: 2732132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FCE 22101 and FCE 22891: in-vitro antibacterial activity at concentrations simulating human plasma levels following intravenous, intramuscular and oral administration.
    Della Bruna C; Jabes D; Rossi R; Younes G; Castellani P
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():119-28. PubMed ID: 2659570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple breakpoint method for measuring effect of antibiotics on endocarditis strains of streptococci.
    Marks J; Paull A
    J Clin Pathol; 1990 Sep; 43(9):774-6. PubMed ID: 2212072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests.
    Barry AL; Jones RN; Thornsberry C
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():17-30. PubMed ID: 2732139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic susceptibility of streptococcal strains associated with infective endocarditis.
    Etienne J; Gruer LD; Fleurette J
    Eur Heart J; 1984 Oct; 5 Suppl C():33-7. PubMed ID: 6394332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative inhibitory and bactericidal activities of FCE 22101 against gram-positive cocci and anaerobes in vitro.
    Maskell JP; Tang T; Asad S; Williams JD
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():65-74. PubMed ID: 2732145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of five combinations of penicillin G with aminoglycosides against Streptococcus faecium.
    Le Bouguenec C; Buu-Hoï A
    Eur Heart J; 1984 Oct; 5 Suppl C():29-32. PubMed ID: 6569841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.
    Watanakunakorn C; Glotzbecker C
    J Med Microbiol; 1977 Feb; 10(1):133-8. PubMed ID: 584243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibacterial activity of netilmicin in combination with other antibiotics. Comparison with other aminoglycosides (author's transl)].
    Cluzel M; Sirot J; Chanal M; Sirot D; Roussanne MC
    Pathol Biol (Paris); 1982 Jun; 30(6):376-9. PubMed ID: 7050845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.